307011000036101: vial (AU qualifier)
Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Oxaliplatin (AS) (oxaliplatin 100 mg) powder for injection, 1 x 100 mg vial (containered trade product pack) | has container type | True | vial | Inferred relationship | Some |  | 
| Oxaliplatin (AS) 50 mg powder for injection, 1 vial | has container type | True | vial | Inferred relationship | Some |  | 
| Fludarabine (AS) 50 mg powder for injection, 1 vial | has container type | True | vial | Inferred relationship | Some |  | 
| Docetaxel (Accord) 160 mg/8 mL injection, 8 mL vial | has container type | True | vial | Inferred relationship | Some |  | 
| Immucyst 81 mg powder for injection, 1 vial | has container type | True | vial | Inferred relationship | Some |  | 
| Riximyo 500 mg/50 mL injection, 2 x 50 mL vials | has container type | True | vial | Inferred relationship | Some |  | 
| Riximyo 100 mg/10 mL injection, 2 x 10 mL vials | has container type | True | vial | Inferred relationship | Some |  | 
| Riximyo 500 mg/50 mL injection, 50 mL vial | has container type | True | vial | Inferred relationship | Some |  | 
| Riximyo (rituximab 100 mg / 10 mL) injection, 3 x 10 mL vials (containered trade product pack) | has container type | True | vial | Inferred relationship | Some |  | 
| Ocrevus 300 mg/10 mL injection, 10 mL vial | has container type | True | vial | Inferred relationship | Some |  | 
Start Previous Page 29 of 29
Reference Sets
Medication container type reference set
Back to Start